1-7 of 7
Prof. Dr. Max S Topp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD19 expression is preserved following CD19-directed monoclonal antibody therapy with tafasitamab

Free
Johannes Duell, Diana Alvarez Arias, Wolfram Klapper, Sarah Reinke, Florian Eisele, Thomas Larsen, Prof. Dr. Max S Topp, Beth Rumberger, TaeHyung (Simon) Kim, Andreas Rosenwald, Hilka Rauert-Wunderlich
Journal: Blood
Blood (2025) 146 (Supplement 1): 5515.
https://doi.org/10.1182/blood-2025-5515
Published: 2025
Journal Articles

Pembro-CORE: Interim analysis of a phase II PET-adapted trial omitting high-dose chemotherapy with PD-1-based salvage in first-relapsed Hodgkin lymphoma

Free
Hishan Tharmaseelan, Sarah Gillessen, Ina Bühnen, Carsten Kobe, Karin G. Schrenk, Prof. Dr. Max S Topp, Ulf Schnetzke, Nico Freund, Stephanie Sasse, Philipp Ernst, Tanja Zamrik, Wolfram Klapper, Michael Fuchs, Sven Borchmann, Paul Bröckelmann, Peter Borchmann, Bastian von Tresckow
Journal: Blood
Blood (2025) 146 (Supplement 1): 5401.
https://doi.org/10.1182/blood-2025-5401
Published: 2025
Journal Articles

Safety and efficacy of surovatamig (AZD0486) in adolescent and adult patients with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL): Updated Results from the Phase 1/2 SYRUS study

Free
Ibrahim Aldoss, Pere Barba, Pau Montesinos, Anna Castleton, Gautam Borthakur, Jae-Ho Yoon, Chieh-Lin Teng, Franco Locatelli, Yosr Hicheri, David Taussig, Bela Patel Wrench, Adam DuVall, Veit Buecklein, Cristina Papayannidis, Nicola Gökbuget, Bijal Shah, Raghuveer Mali, Yuyin Liu, Damilola Olabode, Margaret Wey, Marcio Andrade-Campos, Prof. Dr. Max S Topp, Hagop Kantarjian
Journal: Blood
Blood (2025) 146 (Supplement 1): 3345.
https://doi.org/10.1182/blood-2025-3345
Published: 2025
Journal Articles

SOUNDTRACK-B: A phase 2 single-arm study to evaluate the efficacy and safety of surovatamig (AZD0486) in relapsed or refractory B-cell non-Hodgkin lymphoma

Free
Chan Cheah, Monique Menzies Wojtowicz, Catherine Thieblemont, Martin Hutchings, Prof. Dr. Max S Topp, Won-Seog Kim, Dai Maruyama, Azadeh Shohoudi, Robin Lesley, Wendy Chang, Marlene Zuraek, Mihail Obrocea, Jing-Zhou Hou
Journal: Blood
Blood (2025) 146 (Supplement 1): 3747.
https://doi.org/10.1182/blood-2025-3747
Published: 2025
Journal Articles

A Phase 1 study of KITE-753 or KITE-363 in patients with relapsed/refractory B-cell lymphoma: Initial safety and preliminary efficacy of KITE-753 and updated results of KITE-363

Free
Saurabh Dahiya, Matthew Ulrickson, Jean Yared, Patrick Reagan, Timothy Voorhees, Ran Reshef, Cameron Turtle, Lizamarie Bachier-Rodriguez, Marie José Kersten, Prof. Dr. Max S Topp, Gary Simmons, Robin Sanderson, Loretta Nastoupil, Scott Jung, Enrique Granados, Jinghui Dong, Joshua Winters, Rhine Shen, Justyna Kanska, Myrna Nahas, Sairah Ahmed
Journal: Blood
Blood (2025) 146 (Supplement 1): 265.
https://doi.org/10.1182/blood-2025-265
Published: 2025
Journal Articles

Zilovertamab vedotin plus R-CHP versus polatuzumab vedotin plus R-CHP as first-line therapy in participants with germinal center B-cell diffuse large B-cell lymphoma (DLBCL): The randomized, open-label, Phase 2 waveline-011 Study

Free
Prof. Dr. Max S Topp, Guoqing Wang, Puja Patel, Rushdia Yusuf, David Lavie
Journal: Blood
Blood (2025) 146 (Supplement 1): 5480.
https://doi.org/10.1182/blood-2025-5480
Published: 2025
Journal Articles

Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and adverse outcome of CAR-T therapy

Free
Lukas Scheller, Xiang Zhou, Markus Kreuz, Henry Loeffler-Wirth, Sofie-Katrin Kadel, Sven Schimanski, Hannah Schulze, Anna Marie Ruckdeschel, Florian Eisele, Verena Konetzki, Maria Jornet Culubret, Julia Mersi, Johannes Waldschmidt, Sophia Danhof, Maximilian Merz, Ulrike Koehl, K. Martin Kortüm, Leo Rasche, Hermann Einsele, Johannes Duell, Prof. Dr. Max S Topp, Michael Hudecek, Kristin Reiche, Miriam Alb
Journal: Blood
Blood (2025) 146 (Supplement 1): 809.
https://doi.org/10.1182/blood-2025-809
Published: 2025